Net value dropped $1.65B, with 386 sellers vs 262 buyers; 122 exits vs 70 new buys. No insider trading data is available, so the bearish verdict stems solely from institutional distribution.

Confirmation

Accelerated selling by top holders would confirm the bearish trend.

Invalidation Risk

A surprise shift to net institutional buying in the next quarter would invalidate this verdict.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-14

2026-07-14

Baxter International Inc. is consolidating its reporting segments from three to two, effective in the second quarter of 2026. The new structure combines the former Pharmaceuticals business into the Medical Products & Therapies (MPT) segment, alongside the standalone Healthcare Systems & Technologies (HST) segment. To maintain comparability, Baxter filed recast historical financial data matching the new structure.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding BAXTER INTERNATIONAL INC (BAX)?

Major stakeholders currently include BlackRock, Inc. ($1.3B), Pzena Investment Management LLC ($1.1B), Dodge & Cox ($961.9M). Based on the latest 13F filings, there are a total of 663 tracked investment funds and institutions maintaining positions in BAX.

What is the overall institutional sentiment toward BAX recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.6B, driven by 262 managers accumulating shares while 386 reduced their exposure.

Which institutions have been selling or reducing their BAX positions?

In the latest period, 264 funds trimmed their holdings, and 122 managers completely exited their positions. The aggregate reported sell value was $5.7B.

Are there any notable investors adding BAX to their portfolios?

Yes, buying activity remains notable. 70 institutions opened new positions in {ticker}, and 192 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.2B.